Reportstack

Global Alzheimer's Drugs Market 2012-2016

 

Naperville, IL -- (SBWIRE) -- 06/26/2013 -- Reportstack, provider of premium market research reports announces the addition of Global Alzheimer's Drugs Market 2012-2016 market report to its offering
Analysts forecast the Global Alzheimer's Drugs market to grow at a CAGR of 3.26 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing aging population. The Global Alzheimer's Drugs market has also been witnessing the availability of improved diagnostics. However, numerous patent expiries could pose a challenge to the growth of this market.
Global Alzheimer's Drugs market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Global Alzheimer's Drugs market in the Americas, the EMEA, and the APAC regions, its market landscape, and growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this market space include Eisai Co., Ltd., Forest Laboratories Inc., H. Lundbeck A/S., Novartis AG, and Pfizer Inc.
Key questions answered in this report:
What will the market size be in 2016 and at what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?

Companies Mentioned

Eisai Co., Ltd., Forest Laboratories Inc., H. Lundbeck A/S., Novartis AG, and Pfizer Inc.

To view the table of contents for this market research report please visit
http://www.reportstack.com/product/107834/global-alzheimers-drugs-market-2012-2016.html